# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA624714 | F | Compound was tested for inhibition of cell growth of A-549 cells | Homo sapiens | 12 | ALA1128115 | cell-based format | Scientific Literature | |
2. | ALA857055 | F | Antineoplastic activity against A-549 (human lung carcinoma) cell line. | Homo sapiens | 18 | ALA1131832 | cell-based format | Scientific Literature | |
3. | ALA619445 | F | The compound was evaluated for its cytotoxic potency against A-549 cell line | Homo sapiens | 9 | ALA1132813 | cell-based format | Scientific Literature | |
4. | ALA694324 | F | Antineoplastic activity against HT-29 (human colon adenocarcinoma) cell line. | Homo sapiens | 18 | ALA1131832 | cell-based format | Scientific Literature | |
5. | ALA693870 | F | Compound was tested for inhibition of cell growth of HT-29 cells | Homo sapiens | 12 | ALA1128115 | cell-based format | Scientific Literature | |
6. | ALA873326 | F | The compound was evaluated for its cytotoxic potency against HT-29 cell line | Homo sapiens | 2 | ALA1132813 | cell-based format | Scientific Literature | |
7. | ALA707032 | F | In vitro evaluation of leishmanicidal activity against Leishmania amazonensis (PH8) at a dose 100 ug/mL; +++= total prevention of parasites | Leishmania amazonensis | 9 | ALA1132138 | organism-based format | Scientific Literature | |
8. | ALA707037 | F | In vitro evaluation of leishmanicidal activity against Leishmania amazonensis (PH8) at a dose 50 ug/mL; ++ = 80- 90% lysis | Leishmania amazonensis | 3 | ALA1132138 | organism-based format | Scientific Literature | |
9. | ALA880192 | F | In vitro evaluation of leishmanicidal activity against Leishmania brasiliensis (2903) at a dose 100 ug/mL; +++= total prevention of parasites | Leishmania braziliensis | 9 | ALA1132138 | organism-based format | Scientific Literature | |
10. | ALA707484 | F | In vitro evaluation of leishmanicidal activity against Leishmania brasiliensis (2903) at a dose 50 ug/mL; ++ = 80- 90% lysis | Leishmania braziliensis | 5 | ALA1132138 | organism-based format | Scientific Literature | |
11. | ALA711906 | F | In vitro evaluation of leishmanicidal activity against Leishmania donovani (PP75) at a dose 100 ug/mL; +++= total prevention of parasites | Leishmania donovani | 7 | ALA1132138 | organism-based format | Scientific Literature | |
12. | ALA711910 | F | In vitro evaluation of leishmanicidal activity against Leishmania donovani (PP75) at a dose 50 ug/mL; ++ = 80- 90% lysis | Leishmania donovani | 4 | ALA1132138 | organism-based format | Scientific Literature | |
13. | ALA710057 | F | Antineoplastic activity against SK-MEL-28 (human melanoma) cell line. | Homo sapiens | 17 | ALA1131832 | cell-based format | Scientific Literature | |
14. | ALA710058 | F | The compound was evaluated for its cytotoxic potency against MEL-28 cell line | Homo sapiens | 9 | ALA1132813 | cell-based format | Scientific Literature | |
15. | ALA710059 | F | Compound was tested for inhibition of cell growth of MEL-28 cells | Homo sapiens | 12 | ALA1128115 | cell-based format | Scientific Literature | |
16. | ALA755568 | F | Antineoplastic activity against P-388 (murine lymphoid neoplasm) cell line. | Mus musculus | 18 | ALA1131832 | cell-based format | Scientific Literature | |
17. | ALA756030 | F | Compound was tested for inhibition of cell growth of P-388 cells | Mus musculus | 12 | ALA1128115 | cell-based format | Scientific Literature | |
18. | ALA758604 | F | The compound was evaluated for its cytotoxic potency against P388 cell line | Mus musculus | 9 | ALA1132813 | cell-based format | Scientific Literature | |
19. | ALA834387 | F | Inhibitory concentration value against human A-549 tumor cell line | Homo sapiens | 76 | ALA1145177 | cell-based format | Scientific Literature | |
20. | ALA833793 | F | Inhibitory concentration value against human MEL-28 tumor cell line | Homo sapiens | 44 | ALA1145177 | cell-based format | Scientific Literature |